12 results for author:"Lawrie A." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. Hameed A.G., Arnold N.D., Chamberlain J., Pickworth J.A., Paiva C., Dawson S., Cross S., Long L., Zhao L., Morrell N.W. et al. J. Exp. Med. 209:1919-1935(2012) · Mapped (23) |
| Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study. Ryland J.K., Lawrie A.S., Mackie I.J., Machin S.J. Thromb. Res. 129:447-452(2012) · Mapped (12) |
| Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. Lawrie A., Hameed A.G., Chamberlain J., Arnold N., Kennerley A., Hopkinson K., Pickworth J., Kiely D.G., Crossman D.C., Francis S.E. Am. J. Pathol. 179:1693-1705(2011) · Mapped (17) |
| TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. McGrath E.E., Marriott H.M., Lawrie A., Francis S.E., Sabroe I., Renshaw S.A., Dockrell D.H., Whyte M.K. J. Leukoc. Biol. 90:855-865(2011) · Mapped (7) |
| S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Spiekerkoetter E., Guignabert C., de Jesus Perez V., Alastalo T.P., Powers J.M., Wang L., Lawrie A., Ambartsumian N., Schmidt A.M., Berryman M. et al. Circ. Res. 105:639-47, 13 p following 2009:647-647(2009) · Mapped (20) |
| Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. Lawrie A., Waterman E., Southwood M., Evans D., Suntharalingam J., Francis S., Crossman D., Croucher P., Morrell N., Newman C. Am. J. Pathol. 172:256-264(2008) · Mapped (1) |
| Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden. Lincz L.F., Lonergan A., Scorgie F.E., Rowlings P., Gibson R., Lawrie A., Seldon M. Pathophysiol. Haemost. Thromb. 35:435-439(2006) · Mapped (13) |
| Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Leung W.C., Lawrie A., Demaries S., Massaeli H., Burry A., Yablonsky S., Sarjeant J.M., Fera E., Rassart E., Pickering J.G. et al. Circ. Res. 95:179-186(2004) · Mapped (2) |
| Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Sarjeant J.M., Lawrie A., Kinnear C., Yablonsky S., Leung W., Massaeli H., Prichett W., Veinot J.P., Rassart E., Rabinovitch M. Arterioscler. Thromb. Vasc. Biol. 23:2172-2177(2003) · Mapped (2) |
| Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. Arris C.E., Boyle F.T., Calvert A.H., Curtin N.J., Endicott J.A., Garman E.F., Gibson A.E., Golding B.T., Grant S., Griffin R.J. et al. J. Med. Chem. 43:2797-2804(2000) · Mapped (1) |
| Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. Brown N.R., Noble M.E., Lawrie A.M., Morris M.C., Tunnah P., Divita G., Johnson L.N., Endicott J.A. J. Biol. Chem. 274:8746-8756(1999) · Mapped (2) |
| Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Lawrie A.M., Noble M.E.M., Tunnah P., Brown N.R., Johnson L.N., Endicott J.A. Nat. Struct. Biol. 4:796-801(1997) · UniProtKB (1) |